首页> 外文OA文献 >Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor

【2h】

Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor

机译：ST7612AA1的临床前抗肿瘤活性：一种新的口服硫醇基组蛋白脱乙酰化酶（HDAC）抑制剂

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Loredana Vesci; Elena Bernasconi; Ferdinando Maria Milazzo; Rita De Santis; Eugenio Gaudio; Ivo Kwee; Andrea Rinaldi; Silvia Pace; Valeria Carollo; Giuseppe Giannini; Francesco Bertoni;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Antitumor activity of a novel histone deacetylase inhibitor (S)-HDAC42 in oral squamous cell carcinoma [J] . BaiL.-Y., ChiuC.-F., PanS.-L., Oral oncology . 2011,第12期

机译：新型组蛋白脱乙酰基酶抑制剂（S）-HDAC42在口腔鳞状细胞癌中的抗肿瘤活性
2. Studies of Benzamide-and Thiol-Based Histone Deacetylase Inhibitors in Models of Oxidative-Stress-Induced Neuronal Death: Identification of Some HDAC3-Selective Inhibitors [J] . Yufeng Chen, Rong He, Yihua Chen ChemMedChem . 2009,第5期

机译：氧化应激诱导的神经元死亡模型中的基于苯甲酰胺和硫醇的组蛋白脱乙酰基酶抑制剂的研究：某些HDAC3选择性抑制剂的鉴定。
3. 1255 Clinical and preclinical development of 4SC-201, a new oral histone deacetylase (HDAC) inhibitor [J] . J.de Bono, A.T.Brunetto, R.Kristeleit, European Journal of Cancer Supplements . 2009,第2期

机译：1255新型口服组蛋白脱乙酰基酶（HDAC）抑制剂4SC-201的临床和临床前开发
4. THE NOVEL HDAC INHIBITOR HDAC-42 EXHIBITS BIOLOGIC ACTIVITY AGAINST MALIGNANT MAST CELL TUMORS THROUGH BOTH KIT AND HISTONE DEPENDENT PATHWAYS [C] . Tzu-Yin Lin, Sridhar Murahari, Sam Kulp, Annual Conference of the Veterinary Cancer Society . 2009

机译：新型HDAC抑制剂HDAC-42通过试剂盒和组蛋白依赖性途径对恶性肥大细胞肿瘤进行生物活性
5. Regulation of NF-kappaB activity by the class I histone deacetylases, HDAC1, HDAC2, HDAC3 corepressors and the spermidine/spermine N1 acetyltransferase 2 (SSAT2) coactivator. [D] . Boeke, Marta. 2008

机译：I类组蛋白脱乙酰基酶，HDAC1，HDAC2，HDAC3核心加压因子和亚精胺/精胺N1乙酰转移酶2（SSAT2）共激活剂对NF-κB活性的调节。
6. Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor [O] . Loredana Vesci, Elena Bernasconi, Ferdinando Maria Milazzo, 2015

机译：ST7612AA1的临床前抗肿瘤活性：一种新型的口服硫醇基组蛋白脱乙酰基酶（HDAC）抑制剂
7. Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate [O] . Muthusamy Thangaraju, Senthil K. Karunakaran, Shiro Itagaki, 2009

机译：通过SLC5a8的转运，随后抑制组蛋白脱乙酰酶1（HDAC1）和HDAC3基底下抗肿瘤活性为3-溴吡合他分

Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor

著录项

引文网络

相似文献

相关主题

期刊订阅